Dongji Chen
Publications by Year
Research Areas
MicroRNA in disease regulation, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Rabbits: Nutrition, Reproduction, Health, Glioma Diagnosis and Treatment
Most-Cited Works
- → Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer(2022)423 cited
- → PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells(2015)101 cited
- → Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial(2021)25 cited
- → MicroRNA-31 suppresses the self-renewal capability of α2δ1+ liver tumor-initiating cells by targeting ISL1(2017)7 cited
- → Author Correction: PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells(2019)4 cited
- Preliminary Investigation on the Rabbit Coccidian Infection in Fujian Province(2014)
- → Anesthetic management of precise radiotherapy under apnea-like condition(2021)3 cited
- Effects of salinity on the growth and photosynthetic pigment synthesis of Sargassum hemiphyllum seedings(2015)
- → First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial(2025)1 cited
- → Hypofractionated radiotherapy under functional apnea for right lung metastases: a case report(2016)